Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 421 participants.

Also called NCT01066715

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 421 participants (enrolled count) (from the registry)
Sponsor
XOMA (US) LLC (from the registry)
Registry
  • NCT NCT01066715
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01066715. Randomized; quadruple masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
XOMA 052
Intervention (Drug)
Placebo
Lead sponsor
XOMA (US) LLC (class: industry)

Record details

Record id
cardio:ct-nct01066715
Content hash
e18eb00f913472d01252aa561b09f4ad645a4adbc2280c47518fe5615fc5e458